This document summarizes key information about Staphylococcus aureus and Staphylococci bacteria. It describes their physical characteristics including being Gram positive cocci that form clusters. It then discusses several diseases S. aureus can cause including skin and soft tissue infections, osteomyelitis, endocarditis, toxic shock syndrome, and sepsis. Risk factors for staphylococcal infections and patterns of invasive disease vs. toxin mediated disease are outlined. Specific conditions caused by S. aureus such as impetigo, folliculitis, furuncles, carbuncles, cellulitis, and food poisoning are also detailed.
The document discusses various types of skin and soft tissue infections (SSTIs), including their causes, characteristics, and treatments. It covers cellulitis, abscesses, necrotizing fasciitis, gas gangrene, pyomyositis, diabetic foot infections, and surgical site infections. The key pathogens involved are Staphylococcus aureus, streptococci, anaerobes, and various Gram-negative bacteria. Treatment depends on the infection but generally involves wound drainage, debridement of necrotic tissue if needed, and antibiotics.
This document provides information on bacterial skin infections (pyodermas). It discusses the main pathogens involved, including Staphylococcus aureus and Streptococcus species. It describes the pathogenesis of pyodermas and the factors that can contribute to their development. The document classifies pyodermas and provides details on specific types such as vesiculopustulosis, Finger's pseudofurunculosis, epidemic pemphigus of newborns, staphylococcal scalded skin syndrome, folliculitis, furuncle, and carbuncle. Treatment options are mentioned for severe infections like staphylococcal scalded skin syndrome which typically requires hospitalization and intravenous antibiotics.
Skin infections can be caused by bacteria, viruses, or fungi entering through breaks in the skin or spreading from other sites. Staphylococcus aureus is a common cause and can result in impetigo (pus-filled vesicles), folliculitis (infection of hair follicles), furuncles (boils), or carbuncles (coalesced furuncles). Toxic shock syndrome and scalded skin syndrome are severe illnesses caused by S. aureus toxins. Streptococcus pyogenes commonly causes impetigo, erysipelas (painful skin infection), or scarlet fever (rash following strep throat). Proper treatment depends on identifying the causative agent.
Staphylococcus aureus is a gram-positive, spherical bacterium that can cause several diseases in humans. It is a normal member of the skin and nasal flora but can become pathogenic. S. aureus produces several toxins and enzymes that allow it to infect the skin, blood, lungs, heart, bones and joints. Diseases include impetigo, cellulitis, abscesses, pneumonia, osteomyelitis, endocarditis and toxic shock syndrome. Laboratory diagnosis involves culturing and identifying its characteristic gram-positive cocci in clusters and positive tests for catalase, coagulase and DNase. Treatment involves antibiotics like oxacillin or vancomycin depending on antibiotic resistance.
The document provides information on the history and physiology of infection, along with definitions and classifications of various types of infections such as surgical site infections, sepsis, bacteremia, and abscesses. It traces the history of infection from ancient Egyptians and their mummification practices to modern discoveries like antibiotics. Key physiological defenses against infection like the immune system are described. Various infections affecting wounds, skin and deeper tissues are defined and explained.
Dr. Ali El-ethawi provides an overview of common bacterial skin infections. He discusses the normal skin flora and how changes can allow infections to occur. The most common bacteria that cause skin infections are Staphylococcus aureus and Streptococcus pyogenes, which can result in issues like impetigo, cellulitis, and ecthyma. Rarer causes include Pseudomonas aeruginosa. Treatment involves topical or oral antibiotics based on the specific infection as well as treating any predisposing conditions.
This document provides an overview of common bacterial skin infections, including impetigo, ecthyma, furuncles, carbuncles, erysipelas, cellulitis, staphylococcal scalded skin syndrome, toxic shock syndrome, erythrasma, pitted keratolysis, trichomycosis, scarlet fever, cutaneous anthrax, and syphilis. For each infection, the causative bacteria, signs and symptoms, management, and other key details are discussed.
This document provides information on Staphylococcus, including:
- It is a gram positive coccus that occurs in grape-like clusters and was first observed in human lesions.
- Major species that colonize human skin include S. epidermidis and S. aureus.
- It is a facultative anaerobe that grows well on blood agar and produces beta hemolytic colonies. Identification involves gram staining and tests like catalase and coagulase.
- It can cause a variety of infections like skin abscesses, pneumonia, osteomyelitis and toxic shock syndrome. Virulence factors include adhesins, enzymes, and exotoxins. Antibiotic resistance is common.
The document discusses Staphylococcus bacteria, including S. aureus, S. epidermidis, and S. saprophyticus. S. aureus is a major human pathogen that can cause a variety of infections from local skin lesions to serious systemic infections or toxin-mediated diseases like food poisoning or toxic shock syndrome. Virulence factors and antibiotic resistance patterns are described. The diagnosis and treatment of staphylococcal infections is also summarized.
The document summarizes bacterial, fungal, and viral skin infections and wound infections. It discusses the normal skin flora and how bacteria like Staphylococcus aureus and Streptococcus pyogenes can cause localized or spreading skin infections like boils, cellulitis, and impetigo. It also covers fungal infections caused by dermatophytes and Candida albicans, as well as viral infections like herpes, warts, and hand-foot-and-mouth disease. The document concludes by examining wound infections from surgery, burns, and Clostridium bacteria, along with their diagnosis, treatment, and prevention.
This document provides information about various skin diseases and infections. It begins with an introduction to pathological skin changes and then discusses different types of primary and secondary skin infections. Specific bacterial infections caused by Staphylococcus aureus and group A streptococci are examined. Common skin infections and their symptoms are defined, including impetigo, ecthyma, folliculitis, furuncles, carbuncles, cellulitis, and acne. Diagnosis and treatment of bacterial skin infections is also covered. The document concludes with information about fungal infections such as tinea.
This document provides information on skin and soft tissue infections (SSTIs). It discusses the difference between uncomplicated and complicated SSTIs, giving examples of each. It also provides short notes on specific SSTIs including impetigo, bullous impetigo, erysipelas, and cellulitis. The document further discusses the typical bacterial causes of various SSTIs and treatment approaches.
The document discusses various types of skin and soft tissue infections including impetigo, abscesses, cellulitis, and erysipelas. It describes the typical causative bacteria, clinical presentation, risk factors, diagnosis, and treatment for each type of infection. Key points covered include how Staphylococcus aureus and Streptococcus pyogenes are the most common causes. Proper diagnosis involves considering patient history and symptoms, and treatment often involves antibiotics as well as surgical drainage or debridement for more severe cases such as necrotizing fasciitis.
This document discusses various cutaneous bacterial infections caused by Staphylococcus and Streptococcus bacteria, including impetigo, ecthyma, cellulitis, folliculitis, furuncles, carbuncles, scalded skin syndrome, toxic shock syndrome, perianal cellulitis, and dactylitis. It provides details on the causative organisms, clinical features, investigations, differential diagnoses, and management of each condition.
The document describes the anatomy, histology, microbiology, infections, and types of conjunctivitis of the conjunctiva. It discusses the layers of the palpebral and bulbar conjunctiva. It covers bacterial, chlamydial, and viral conjunctivitis as well as allergic, cicatricial, and toxic conjunctivitis. Specific conditions like trachoma and ophthalmia neonatorum are described in detail, including their etiology, clinical features, diagnosis and management.
This document discusses bacterial infections of the skin. It begins by describing the natural defenses of skin and normal skin flora. It then discusses the different types of primary and secondary skin infections, including impetigo, folliculitis, furuncles, carbuncles, cellulitis, erysipelas, cutaneous abscesses, and necrotizing fasciitis. It provides details on specific bacterial infections caused by Staphylococcus aureus and streptococci. The document concludes with sections on laboratory diagnosis of skin infections and principles of therapy.
Skin conditions of surgical Importance.pptxDakaneMaalim
油
This document summarizes common skin conditions and infections of surgical importance. It discusses bacterial infections like folliculitis, furuncles, carbuncles and cellulitis. It also covers fungal infections like actinomycosis and viral infections like human papilloma virus. Benign and malignant skin tumors are outlined. Deeper skin infections such as necrotizing fasciitis, pyomyositis and hidradenitis suppurativa are also described. Diagnostic testing, treatment options and management approaches are provided for many of the conditions.
Bacterial infections of the skin can be either primary (caused by a single pathogen affecting normal skin) or secondary (occurring in already diseased skin). Common primary pathogens include Staphylococcus aureus, beta-hemolytic streptococci, and coryneform bacteria. S. aureus is responsible for infections like impetigo, folliculitis, furuncles, carbuncles, scalded skin syndrome, and toxic shock syndrome. Group A beta-hemolytic streptococci cause impetigo and cellulitis. Other bacterial infections include ecthyma, erysipelas, cellulitis, cutaneous abscesses, and necrotizing fasciitis. Laboratory diagnosis involves specimen collection
This document provides information on Staphylococcus aureus, including its classification, morphology, culture characteristics, biochemical properties, virulence factors, pathogenesis, clinical syndromes, laboratory diagnosis, treatment, and MRSA. S. aureus is a Gram-positive coccus that occurs in clusters and can cause a variety of infections on the skin and deeper tissues. It is classified based on pigment production and coagulase testing. Diagnosis involves culture, microscopy, and biochemical tests. Treatment depends on the infection type and may involve antibiotics, wound drainage, and device removal.
The document discusses various skin conditions including acute and chronic inflammatory diseases, infections, and neoplasms. It provides details on the pathogenesis, clinical features, and histopathology of conditions like urticaria, eczema, psoriasis, lichen planus, impetigo, fungal infections, viral infections including warts and molluscum, and acne. Case studies are presented to demonstrate clinical presentations.
This document discusses various types of skin and soft tissue infections, including their causes, symptoms, and treatments. It covers primary infections like impetigo caused by streptococci or staphylococci and secondary infections like cellulitis. Deeper infections involving fascia and muscles are also outlined, such as necrotizing fasciitis caused by streptococci or clostridia. The diagnostic process involves specimen collection, microscopy, and bacterial culture and identification. Proper treatment depends on the identified pathogen and may involve antibiotics, surgery, or both.
Microbiology is the study of microorganisms that can only be seen with a microscope. Historical evidence shows early civilizations isolated infected individuals and burned soiled dressings. Girolamo Fracastorius first suggested disease was caused by living germs in 1546. Robert Koch developed culture plates in 1876 and Louis Pasteur developed sterilization methods. Microorganisms include bacteria, viruses, fungi, parasites and can be pathogenic or non-pathogenic. The human body defends against infection through mechanical barriers, inflammation, phagocytosis, and specific and non-specific immune responses using B cells, T cells and antibodies.
This seminar consisits of description of various bacterial diseases along with their oral manifestations,diagnosis and treatment.an addition of suitable case reports for better understanding and associated disorders
Bacterial infections of the oral cavity can take many forms. Scarlet fever is caused by Streptococcus bacteria and presents with a red rash and strawberry tongue. Tuberculosis is caused by Mycobacterium tuberculosis and typically causes lesions in the lungs but can also cause oral ulcers, gingivitis, and osteomyelitis of the jaw. Diphtheria is caused by Corynebacterium diphtheriae and presents with a diphtheritic membrane that can cover the tonsils, soft palate, and throat.
1. Surgical infections can occur through invasion of microorganisms following breakdown of host defenses. Common types include surgical site infections, cellulitis, and abscesses which are usually caused by bacteria on the skin and treated with antibiotics and drainage.
2. Specific infections like gas gangrene, tetanus, and necrotizing fasciitis occur when certain bacteria invade wounds. Gas gangrene caused by Clostridium perfringens produces tissue gangrene and gas, while tetanus toxin causes painful muscle spasms. Necrotizing fasciitis is a severe soft tissue infection treated aggressively with debridement and antibiotics.
3. Preventing and properly treating wounds can reduce risk of
Non-Invasive ICP Monitoring for NeurosurgeonsDhaval Shukla
油
This presentation delves into the latest advancements in non-invasive intracranial pressure (ICP) monitoring techniques, specifically tailored for neurosurgeons. It covers the importance of ICP monitoring in clinical practice, explores various non-invasive methods, and discusses their accuracy, reliability, and clinical applications. Attendees will gain insights into the benefits of non-invasive approaches over traditional invasive methods, including reduced risk of complications and improved patient outcomes. This comprehensive overview is designed to enhance the knowledge and skills of neurosurgeons in managing patients with neurological conditions.
Invasive systems are commonly used for monitoring intracranial pressure (ICP) in traumatic brain injury (TBI) and are considered the gold standard. The availability of invasive ICP monitoring is heterogeneous, and in low- and middle-income settings, these systems are not routinely employed due to high cost or limited accessibility. The aim of this presentation is to develop recommendations to guide monitoring and ICP-driven therapies in TBI using non-invasive ICP (nICP) systems.
1. Explain the physiological control of glomerular filtration and renal blood flow
2. Describe the humoral and autoregulatory feedback mechanisms that mediate the autoregulation of renal plasma flow and glomerular filtration rate
The document discusses Staphylococcus bacteria, including S. aureus, S. epidermidis, and S. saprophyticus. S. aureus is a major human pathogen that can cause a variety of infections from local skin lesions to serious systemic infections or toxin-mediated diseases like food poisoning or toxic shock syndrome. Virulence factors and antibiotic resistance patterns are described. The diagnosis and treatment of staphylococcal infections is also summarized.
The document summarizes bacterial, fungal, and viral skin infections and wound infections. It discusses the normal skin flora and how bacteria like Staphylococcus aureus and Streptococcus pyogenes can cause localized or spreading skin infections like boils, cellulitis, and impetigo. It also covers fungal infections caused by dermatophytes and Candida albicans, as well as viral infections like herpes, warts, and hand-foot-and-mouth disease. The document concludes by examining wound infections from surgery, burns, and Clostridium bacteria, along with their diagnosis, treatment, and prevention.
This document provides information about various skin diseases and infections. It begins with an introduction to pathological skin changes and then discusses different types of primary and secondary skin infections. Specific bacterial infections caused by Staphylococcus aureus and group A streptococci are examined. Common skin infections and their symptoms are defined, including impetigo, ecthyma, folliculitis, furuncles, carbuncles, cellulitis, and acne. Diagnosis and treatment of bacterial skin infections is also covered. The document concludes with information about fungal infections such as tinea.
This document provides information on skin and soft tissue infections (SSTIs). It discusses the difference between uncomplicated and complicated SSTIs, giving examples of each. It also provides short notes on specific SSTIs including impetigo, bullous impetigo, erysipelas, and cellulitis. The document further discusses the typical bacterial causes of various SSTIs and treatment approaches.
The document discusses various types of skin and soft tissue infections including impetigo, abscesses, cellulitis, and erysipelas. It describes the typical causative bacteria, clinical presentation, risk factors, diagnosis, and treatment for each type of infection. Key points covered include how Staphylococcus aureus and Streptococcus pyogenes are the most common causes. Proper diagnosis involves considering patient history and symptoms, and treatment often involves antibiotics as well as surgical drainage or debridement for more severe cases such as necrotizing fasciitis.
This document discusses various cutaneous bacterial infections caused by Staphylococcus and Streptococcus bacteria, including impetigo, ecthyma, cellulitis, folliculitis, furuncles, carbuncles, scalded skin syndrome, toxic shock syndrome, perianal cellulitis, and dactylitis. It provides details on the causative organisms, clinical features, investigations, differential diagnoses, and management of each condition.
The document describes the anatomy, histology, microbiology, infections, and types of conjunctivitis of the conjunctiva. It discusses the layers of the palpebral and bulbar conjunctiva. It covers bacterial, chlamydial, and viral conjunctivitis as well as allergic, cicatricial, and toxic conjunctivitis. Specific conditions like trachoma and ophthalmia neonatorum are described in detail, including their etiology, clinical features, diagnosis and management.
This document discusses bacterial infections of the skin. It begins by describing the natural defenses of skin and normal skin flora. It then discusses the different types of primary and secondary skin infections, including impetigo, folliculitis, furuncles, carbuncles, cellulitis, erysipelas, cutaneous abscesses, and necrotizing fasciitis. It provides details on specific bacterial infections caused by Staphylococcus aureus and streptococci. The document concludes with sections on laboratory diagnosis of skin infections and principles of therapy.
Skin conditions of surgical Importance.pptxDakaneMaalim
油
This document summarizes common skin conditions and infections of surgical importance. It discusses bacterial infections like folliculitis, furuncles, carbuncles and cellulitis. It also covers fungal infections like actinomycosis and viral infections like human papilloma virus. Benign and malignant skin tumors are outlined. Deeper skin infections such as necrotizing fasciitis, pyomyositis and hidradenitis suppurativa are also described. Diagnostic testing, treatment options and management approaches are provided for many of the conditions.
Bacterial infections of the skin can be either primary (caused by a single pathogen affecting normal skin) or secondary (occurring in already diseased skin). Common primary pathogens include Staphylococcus aureus, beta-hemolytic streptococci, and coryneform bacteria. S. aureus is responsible for infections like impetigo, folliculitis, furuncles, carbuncles, scalded skin syndrome, and toxic shock syndrome. Group A beta-hemolytic streptococci cause impetigo and cellulitis. Other bacterial infections include ecthyma, erysipelas, cellulitis, cutaneous abscesses, and necrotizing fasciitis. Laboratory diagnosis involves specimen collection
This document provides information on Staphylococcus aureus, including its classification, morphology, culture characteristics, biochemical properties, virulence factors, pathogenesis, clinical syndromes, laboratory diagnosis, treatment, and MRSA. S. aureus is a Gram-positive coccus that occurs in clusters and can cause a variety of infections on the skin and deeper tissues. It is classified based on pigment production and coagulase testing. Diagnosis involves culture, microscopy, and biochemical tests. Treatment depends on the infection type and may involve antibiotics, wound drainage, and device removal.
The document discusses various skin conditions including acute and chronic inflammatory diseases, infections, and neoplasms. It provides details on the pathogenesis, clinical features, and histopathology of conditions like urticaria, eczema, psoriasis, lichen planus, impetigo, fungal infections, viral infections including warts and molluscum, and acne. Case studies are presented to demonstrate clinical presentations.
This document discusses various types of skin and soft tissue infections, including their causes, symptoms, and treatments. It covers primary infections like impetigo caused by streptococci or staphylococci and secondary infections like cellulitis. Deeper infections involving fascia and muscles are also outlined, such as necrotizing fasciitis caused by streptococci or clostridia. The diagnostic process involves specimen collection, microscopy, and bacterial culture and identification. Proper treatment depends on the identified pathogen and may involve antibiotics, surgery, or both.
Microbiology is the study of microorganisms that can only be seen with a microscope. Historical evidence shows early civilizations isolated infected individuals and burned soiled dressings. Girolamo Fracastorius first suggested disease was caused by living germs in 1546. Robert Koch developed culture plates in 1876 and Louis Pasteur developed sterilization methods. Microorganisms include bacteria, viruses, fungi, parasites and can be pathogenic or non-pathogenic. The human body defends against infection through mechanical barriers, inflammation, phagocytosis, and specific and non-specific immune responses using B cells, T cells and antibodies.
This seminar consisits of description of various bacterial diseases along with their oral manifestations,diagnosis and treatment.an addition of suitable case reports for better understanding and associated disorders
Bacterial infections of the oral cavity can take many forms. Scarlet fever is caused by Streptococcus bacteria and presents with a red rash and strawberry tongue. Tuberculosis is caused by Mycobacterium tuberculosis and typically causes lesions in the lungs but can also cause oral ulcers, gingivitis, and osteomyelitis of the jaw. Diphtheria is caused by Corynebacterium diphtheriae and presents with a diphtheritic membrane that can cover the tonsils, soft palate, and throat.
1. Surgical infections can occur through invasion of microorganisms following breakdown of host defenses. Common types include surgical site infections, cellulitis, and abscesses which are usually caused by bacteria on the skin and treated with antibiotics and drainage.
2. Specific infections like gas gangrene, tetanus, and necrotizing fasciitis occur when certain bacteria invade wounds. Gas gangrene caused by Clostridium perfringens produces tissue gangrene and gas, while tetanus toxin causes painful muscle spasms. Necrotizing fasciitis is a severe soft tissue infection treated aggressively with debridement and antibiotics.
3. Preventing and properly treating wounds can reduce risk of
Non-Invasive ICP Monitoring for NeurosurgeonsDhaval Shukla
油
This presentation delves into the latest advancements in non-invasive intracranial pressure (ICP) monitoring techniques, specifically tailored for neurosurgeons. It covers the importance of ICP monitoring in clinical practice, explores various non-invasive methods, and discusses their accuracy, reliability, and clinical applications. Attendees will gain insights into the benefits of non-invasive approaches over traditional invasive methods, including reduced risk of complications and improved patient outcomes. This comprehensive overview is designed to enhance the knowledge and skills of neurosurgeons in managing patients with neurological conditions.
Invasive systems are commonly used for monitoring intracranial pressure (ICP) in traumatic brain injury (TBI) and are considered the gold standard. The availability of invasive ICP monitoring is heterogeneous, and in low- and middle-income settings, these systems are not routinely employed due to high cost or limited accessibility. The aim of this presentation is to develop recommendations to guide monitoring and ICP-driven therapies in TBI using non-invasive ICP (nICP) systems.
1. Explain the physiological control of glomerular filtration and renal blood flow
2. Describe the humoral and autoregulatory feedback mechanisms that mediate the autoregulation of renal plasma flow and glomerular filtration rate
Creatines Untold Story and How 30-Year-Old Lessons Can Shape the FutureSteve Jennings
油
Creatine burst into the public consciousness in 1992 when an investigative reporter inside the Olympic Village in Barcelona caught wind of British athletes using a product called Ergomax C150. This led to an explosion of interest in and questions about the ingredient after high-profile British athletes won multiple gold medals.
I developed Ergomax C150, working closely with the late and great Dr. Roger Harris (1944 2024), and Prof. Erik Hultman (1925 2011), the pioneering scientists behind the landmark studies of creatine and athletic performance in the early 1990s.
Thirty years on, these are the slides I used at the Sports & Active Nutrition Summit 2025 to share the story, the lessons from that time, and how and why creatine will play a pivotal role in tomorrows high-growth active nutrition and healthspan categories.
Dr. Anik Roy Chowdhury
MBBS, BCS(Health), DA, MD (Resident)
Department of Anesthesiology, ICU & Pain Medicine
Shaheed Suhrawardy Medical College Hospital (ShSMCH)
Optimization in Pharmaceutical Formulations: Concepts, Methods & ApplicationsKHUSHAL CHAVAN
油
This presentation provides a comprehensive overview of optimization in pharmaceutical formulations. It explains the concept of optimization, different types of optimization problems (constrained and unconstrained), and the mathematical principles behind formulation development. Key topics include:
Methods for optimization (Sequential Simplex Method, Classical Mathematical Methods)
Statistical analysis in optimization (Mean, Standard Deviation, Regression, Hypothesis Testing)
Factorial Design & Quality by Design (QbD) for process improvement
Applications of optimization in drug formulation
This resource is beneficial for pharmaceutical scientists, R&D professionals, regulatory experts, and students looking to understand pharmaceutical process optimization and quality by design approaches.
Unit 1: Introduction to Histological and Cytological techniques
Differentiate histology and cytology
Overview on tissue types
Function and components of the compound light microscope
Overview on common Histological Techniques:
o Fixation
o Grossing
o Tissue processing
o Microtomy
o Staining
o Mounting
Application of histology and cytology
legal Rights of individual, children and women.pptxRishika Rawat
油
A legal right is a claim or entitlement that is recognized and protected by the law. It can also refer to the power or privilege that the law grants to a person. Human rights include the right to life and liberty, freedom from slavery and torture, freedom of opinion and expression, the right to work and education
Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...KHUSHAL CHAVAN
油
This presentation provides an in-depth understanding of solubilization and its critical role in pharmaceutical formulations. It covers:
Definition & Mechanisms of Solubilization
Role of surfactants, micelles, and bile salts in drug solubility
Factors affecting solubilization (pH, polarity, particle size, temperature, etc.)
Methods to enhance drug solubility (Buffers, Co-solvents, Surfactants, Complexation, Solid Dispersions)
Advanced approaches (Polymorphism, Salt Formation, Co-crystallization, Prodrugs)
This resource is valuable for pharmaceutical scientists, formulation experts, regulatory professionals, and students interested in improving drug solubility and bioavailability.
Presentaci坦 que va acompanyar la demostraci坦 prctica de metge d'Innovaci坦 Jos辿 Ferrer sobre el projecte Benestar de BSA, nom d'IDIAP Pere Gol, el 5 de mar巽 de 2025 a l'estand de XarSMART al Mobible Word Congress.
PERSONALITY DEVELOPMENT & DEFENSE MECHANISMS.pptxPersonality and environment:...ABHAY INSTITUTION
油
Personality theory is a collection of ideas that explain how a person's personality develops and how it affects their behavior. It also seeks to understand how people react to situations, and how their personality impacts their relationships.
Key aspects of personality theory
Personality traits: The characteristics that make up a person's personality.
Personality development: How a person's personality develops over time.
Personality disorders: How personality theories can be used to study personality disorders.
Personality and environment: How a person's personality is influenced by their environment.
Chair and Presenters Sara A. Hurvitz, MD, FACP, Carey K. Anders, MD, FASCO, and Vyshak Venur, MD, discuss metastatic HER2-positive breast cancer in this CME/NCPD/CPE/AAPA/IPCE activity titled Fine-Tuning the Selection and Sequencing of HER2-Targeting Therapies in HER2-Positive MBC With and Without CNS Metastases: Expert Guidance on How to Individualize Therapy Based on Latest Evidence, Disease Features, Treatment Characteristics, and Patient Needs and Preferences. For the full presentation, downloadable Practice Aids, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at https://bit.ly/4f8sUs7. CME/NCPD/CPE/AAPA/IPCE credit will be available until March 2, 2026.
1. Staphylococci
Facultative, non-sporulating, non-motile, Gram positive
cocci
Cell Division 3 planes
Daughter cells dont fully separate form clusters
Greek nouns
Staphyle a bunch of grapes
Coccus grain or berry
2. Disease Manifestations due
to Staphylococcus aureus
Skin and soft tissue
infections
Impetigo
Osteomyelitis
Endocarditis
Septic phlebitis
Catheter infections
Toxic shock syndrome
Septicemia
3. Disease Manifestations due
to Staphylococcus aureus
Skin and soft tissue
infections
Impetigo
Cellulite
Osteomyelitis
Pneumonia
Endocarditis
Septic phlebitis
Catheter infections
Surgical site infections
Toxic shock syndrome
Septicemia
Septic arthritis
4. Staphylococci
27 species Three Important Species
Staphylococcus aureus
Important human pathogen
Staphylococcus epidermidis
Normal skin flora, disease under special circumstances
Staphylococcus saprophyticus
UTIs in young females
6. S. aureus - Epidemiology
Reservoir Humans
Asymptomatic Carriage Sites:
Nares
Rectum
Perineum
Pharynx
Skin Colonization - Brief, Repeated
Transmission - Person to Person
7. S. aureus Carriage Rates
Population Carriage Rate (%)
General Population 25
Hemodialysis 75
Diabetic on insulin 50
Patients receiving 50
allergy shots
Intravenous Drug Users 40
8. Staphylococcal Infections - Risk Factors
Skin Disease
Increased colonization
Trauma
Expose binding sites
Viral Respiratory Tract
Infection (Influenza)
Expose binding sites
Decreased clearance
Foreign Body
Liver disease
Neoplasia
Diabetes
Renal Failure
Leukocyte &
Immunoglobulin Defects
Elevated Serum IgE
Levels
Narcotics Addiction
Broad Spectrum Antibiotic
Therapy
In general Healthy people dont get serious Staph infections
9. Patterns of Disease - S. aureus
1) Invasion with Tissue Destruction
2) Toxin Mediated
10. Patterns of Disease - S. aureus
1) Invasion with Tissue Destruction
2) Toxin Mediated
Toxic Shock Syndrome
Scalded Skin Syndrome
Staphylococcal Food Poisoning
17. A 22-month-old boy with a
staphylococcal folliculitis on the buttocks.
The lesions have been excoriated. Diaper
occlusion may have been related to onset
of the rash.
18. Furuncle
Often starts as infection of
hair follicle Folliculitis
Firm, tender red nodule
Painful
Fluctuant with time Drain
spontaneously
39. Interventions
Good general hygiene
Wash gently with soap and water
Topical antibiotic therapy
Wash hands
Systemic antibiotics only if severe
and does not respond to topical.
(keflex po)
44. Cellulitis
A full-thickness skin infection
involving dermis and underlying
connective tissue.
Any part of the body can be
affected.
Cellulitis around the eyes is usually
an extension of a sinus infection or
otitis media.
46. Assessment
History and physical exam
WBC count
Blood culture
Culturing organism from lesion
aspiration.
CT scan with peri-orbital cellulitis
47. Clinical Manifestations
Characteristic reddened or lilac-
colored, swollen skin that pits when
pressed with finger.
Borders are indistinct.
Warm to touch.
Superficial blistering.
70. Interventions
Hospitalization if large area involved
or facial cellulitis.
IV antibiotics.
Pain management.
Warm moist packs to area if ordered.
Assess for spread
If peri-orbital test for ocular
movement and vision acuity
76. Expansion of abscess
Periosteal elevation
Shearing of arteries
Subperiosteal
abscess
Reactive bone
Ischemia = osteonecrosis (sequestrum)
Pyogenic osteomyelitis -pathogenesis
77. Pus in joint
Extension into soft tissue
Draining sinus
Skin
Cortical necrosis =
sequestrum
Reactive bone surround
sequestrum: involucrum
Continuous resorption
Continuous new bone
and fibrosis of marrow
sequestrum
Pyogenic osteomyelitis -pathogenesis
93. Patterns of Disease - S. aureus
1) Invasion with Tissue Destruction
2) Toxin Mediated
Toxic Shock Syndrome
Scalded Skin Syndrome
Staphylococcal Food Poisoning
94. TOXIC SHOCK SYNDROME
Acute Febrile Illness
Subsequent Development of Hypotension
and Shock.
Noted association with S. aureus phage
group I
Named the illness "Toxic Shock Syndrome
95. TOXIC SHOCK SYNDROME
1990 - More than 3,300 cases have been
reported
95% in women
90% occurred during menstruation in
women who were using tampons
1989 - 61 cases of TSS reported
96. Toxic Shock Syndrome -
Epidemiology
1. Menstrual
Colonization of the Vagina and Cervix
with TSST-1 producing strains of S.
aureus
Tampon Associated
Risk proportional to the absorbancy of Tampon
Not tampon associated
98. Pyrogenic Toxin
Family of Proteins secreted by
S. aureus
Strep pyogenes
Include
TSST-1
Staphylococcal Enterotoxins A, B,C
Pyrogenic Exotoxin A & B
Streptococcal Scarlet Fever Toxins A, B,C
99. Toxic Shock Syndrome
- Clinical Manifestations
1. High Fever (>39.9oC)
2. Scarlatiniform Eruption
3. Hypotension and Shock
4. Desquamation during
convalescence
100. Staphylococcal toxic shock
syndrome
Toxic shock syndrome (TSS)
Toxic shock syndrome toxin
(TSST-1)
Super antigen
Tampon or infected wound, TSST-
1 enters blood stream and cause
fever, rash, exfoliation of skin and
shock (death rate 3%)
101. Manifestations of Specific Organ
Involvement
Mucous Membranes: hyperemia
Gastrointestinal Tract: vomiting and diarrhea
Muscle: severe myalgias
Central Nervous System: disorientation
Kidney: azotemia, pyuria urinary tract infection
Liver: elevation of serum bilirubin and SGOT
Blood: Thrombocytopenia
102. Toxic Shock Syndrome -
Diagnosis
Isolation of toxin producing S. aureus
from a patient with a compatible
clinical illness.
103. Toxic Shock Syndrome -
Treatment
1) Treatment of Hypotension and Shock
Vigorous Fluid Replacement
2) Attention to the Site of S. aureus Colonization
Removal of Tampons
Drainage of Staphylococcal Abscess
3) Anti-Staphylococcal Antibiotic Therapy
104. STAPHYLOCOCCAL SCALDED SKIN SYNDROME
A Disease of Infants
Localized Infection with Diffuse Skin Rash
S. aureus (Phage group II) recovered from:
Nose
Pustules
Eye
Umbilicus
Exfoliative Toxin
Two Serologically and Biologically Distinct Proteins
Exfoliatin A
Exfoliatin B
Inter-Epithelial Splitting of Stratum Granulosum Layer
105. Staphylococcal Scalded Skin Syndrome -
Clinical Features
Starts Abruptly
Perioral erythema
Sunburn like, tender rash
spreads over entire body
Bullae Appear Rapidly
Nikolsky sign
Flaccid bullae slough off
Denuded areas
106. Staphylococcal Scalded Skin Syndrome -
Clinical Features
Exfoliated Areas Eventually Dry
Flaky desquamation lasting 3-5
days
Within 10 days After Onset
Complete Recovery
New epidermis has replaced the
denuded areas
110. Staphylococcal Food Poisoning
20% of Outbreaks of Acute Food
Poisoning
Toxigenic Strain of S. aureus growing in
contaminated food
Produces Enterotoxin B (Heat Stable)
Person to Person Transmission
Responsible organism usually isolated from person
involved meal preparation
111. Staphylococcal Food Poisoning
Commonly implicated foods
Custard filled bakery good
Canned food
Potato salad
Ice cream
Food appears normal in
appearance, odor and taste
112. Staphylococcal Food Poisoning -
Clinical Features
Incubation period 2-6 hours
Enterotoxin stimulates intestinal
peristalsis and CNS
Abrupt onset:
Salivation
Nausea and vomiting
Abdominal cramps
Watery diarrhea
Afebrile
Self limited, symptoms disappear in 8 hours
114. S. aureus
Evolution of Drug Resistance in S. aureus
Methicillin
[1970s]
Methicillin-
resistant
S. aureus (MRSA)
S. aureus
Penicillin
[1950s]
Penicillin-resistant
Vancomycin-resistant
enterococci (VRE)
Vancomycin
[1990s]
[1997]
Vancomycin
intermediate-
resistant
S. aureus
(VISA)
[ 2002 ]
Vancomycin-
resistant
S. aureus
115. Bone5:
7%13%
Vancomycin Penetration
Sternal Bone1:
57%
Heart Valve4:
12%
CNS:
<10%
Fat4:
14%
Muscle4:
9%
Epithelial
lining fluid3:
18%
Lung tissue2:
17%24%
1. Massias L et al. Antimicrob Agents Chemother. 1992;36:2539-2541; 2. Cruciani M et al. J Antimicrob
Chemother. 1996;38:865-869. 3. Lamer C et al. Antimicrob Agents Chemother. 1993;37:281-286;
116. MRSA in Europe.
In England and Wales, from
January to December 1999
methicillin resistance was
37% of the S.aureus reports.
Except Scandinavia and
Netherlands most countries
have high rates of MRSA.
119. Reservoir for the Spread of
Antibiotic Resistant Pathogens
clinical
infections
colonized
(asymptomatic)
120. Standard Precautions for Health
Care workers include:
Hand hygiene / handwashing- before and after
patient contact and after touching contaminated
items
Gloving - when touching blood, body fluids,
secretions, excretions,and contaminated items
Masking if aerosol of infectious material
expected
Gowning
Appropriate handling of laundry
121. Most common mode of
transmission of pathogens is via
hands!
So Why All the Fuss About
Hand Hygiene?
122. The Inanimate Environment Can
Facilitate Transmission
~ Contaminated surfaces increase cross-transmission ~
Abstract: The Risk of Hand and Glove Contamination after Contact with a
VRE (+) Patient Environment. Hayden M, ICAAC, 2001, Chicago, IL.
X represents VRE culture positive sites
123. Staphylococcus epidermidis
Normal Flora
Virtually all humans carry S. epidermidis on the skin
and in and around body orifices
Hospital Acquired Infection
Contamination by S. epidermidis carried by the patient
most important event in infections associated
with foreign bodies
125. S. epidermidis - Patterns of Infection
Nosocomial Bacteremia -most common cause
Endocarditis
A. Native Valve
Uncommon- 5% of cases
B. Prosthetic Valve
Single most common cause (40% of cases)
Probably caused by inoculation at the time
of surgery
Indolent course
126. S. epidermidis - Patterns of Infection
Intravenous Catheters
-Single most common cause (50-75% of cases)
Cerebrospinal Fluid Shunts
Peritoneal Dialysis Catheter
Vascular Grafts
Prosthetic Joints
127. S. epidermidis Infection -
Treatment
1. Antimicrobial Therapy
Usually resistant to multiple antibiotics
Beta lactams
Erythromycin, Clindamycin, Tetracycline
Require therapy with Vancomycin
2. Removal of Foreign Body
128. Staphylococcus saprophyticus
Colonizes the genitourinary mucosa of some young
women
Causes both upper and lower urinary tract disease
95% of cases are in females 16-35 years old
Responsible for 20% of the UTI's in this age group
Second only to E. coli
Pathogen of young, sexually active females
70% sexual intercourse within 24 hours preceding onset of
symptoms